Patents by Inventor Ghilsoo Nam

Ghilsoo Nam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8492384
    Abstract: Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: July 23, 2013
    Assignee: Korea Institute of Science and Technology
    Inventors: Kyung Il Choi, Ghilsoo Nam, Hye Ran Kim, Hyewhon Rhim, Seon Hee Seo, Yoon Jee Kim, Hee Sup Shin, Dong Jin Kim, Ae Nim Pae, Hye Jin Chung, Yong Seo Cho, Hyunah Choo, Eun Joo Roh, Soon Bang Kang, Kye Jung Shin, Hoh Gyu Hahn, Dong Yun Shin, Chan Seong Cheong, Kee Dal Nam, Yong Koo Kang, Jae Kyun Lee, Woong Seo Park, Youngsoo Kim, Eunice Eun-Kyeong Kim, Key-Sun Kim, Hesson Chung, Gyo Chang Keum, Cheolju Lee, Kee Hyun Choi
  • Patent number: 8383631
    Abstract: Provided are a novel 1,6-disubstituted-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-7-one compound, a pharmaceutically acceptable salt compound thereof, a method for preparing the compound, and an anticancer pharmaceutical composition including the compound as an effective ingredient.
    Type: Grant
    Filed: September 16, 2010
    Date of Patent: February 26, 2013
    Assignee: Korea Institute of Science and Technology
    Inventors: Ghilsoo Nam, Ae Nim Pae, Kyung Il Choi, Hyunah Choo, Vani Nelamane Devegowda, Seon Hee Seo
  • Patent number: 8299072
    Abstract: The present invention relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts effective as calcium channel modulators and a method of manufacturing the same. The present invention also relates to the medicinal use of the above compounds as therapeutic treatment of diseases due to their effect as calcium channel modulators.
    Type: Grant
    Filed: September 28, 2009
    Date of Patent: October 30, 2012
    Assignee: Korea Institute of Science and Technology
    Inventors: Ghilsoo Nam, Kyung Il Choi, Hye Ran Kim, Seon Hee Seo, Yoon Jee Kim, Hee Sup Shin, Dong Jin Kim, Ae Nim Pae, Hye Jin Chung, Hyunah Choo, Hyewhon Rhim, Yong Seo Cho, Eun Joo Roh, Gyo Chang Keum, Kee Hyun Choi, Kye Jung Shin, Hoh Gyu Hahn, Chan Seong Cheong, Jae Kyun Lee, Kee Dal Nam, Yong Koo Kang, Youngsoo Kim, Woong Seo Park, Eunice Eun-Kyeong Kim, Key-Sun Kim, Hesson Chung, Dong Yun Shin, Chi man Song
  • Publication number: 20110319619
    Abstract: Provided are a novel 1,6-disubstituted-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-7-one compound, a pharmaceutically acceptable salt compound thereof, a method for preparing the compound, and an anticancer pharmaceutical composition including the compound as an effective ingredient.
    Type: Application
    Filed: September 16, 2010
    Publication date: December 29, 2011
    Applicant: Korea Institute of Science and Technology
    Inventors: Ghilsoo NAM, Ae Nim Pae, Kyung Il Choi, Hyunah Choo, Vani Nelamane Devegowda, Seon Hee Seo
  • Publication number: 20100094006
    Abstract: The present invention relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts effective as calcium channel modulators and a method of manufacturing the same. The present invention also relates to the medicinal use of the above compounds as therapeutic treatment of diseases due to their effect as calcium channel modulators.
    Type: Application
    Filed: September 28, 2009
    Publication date: April 15, 2010
    Inventors: Ghilsoo NAM, Kyung Il Choi, Hye Ran Kim, Seon Hee Seo, Yoon Jee Kim, Hee Sup Shin, Dong Jin Kim, Ae Nim Pae, Hye Jin Chung, Hyunah Choo, Hyewhon Rhim, Yong Seo Cho, Eun Joo Roh, Gyo Chang Keum, Kee Hyun Choi, Kye Jung Shin, Hoh Gyu Hahn, Chan Seong Cheong, Jae Kyun Lee, Kee Dal Nam, Yong Koo Kang, Youngsoo Kim, Woong Seo Park, Eunice Eun-Kyeong Kim, Key-Sun Kim, Hesson Chung, Dong Yun Shin, Chi man Song
  • Publication number: 20100004286
    Abstract: Disclosed are isoindolinone derivatives, represented by Chemical Formula 1, having inhibitory activity against T-type calcium channels, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition comprising the same as an active ingredient. wherein R1˜R6 are as defined in the specification.
    Type: Application
    Filed: October 23, 2008
    Publication date: January 7, 2010
    Applicant: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Yong Seo CHO, Ae Nim PAE, Hyunah CHOO, Jae Kyun LEE, You Na OH, Hee Sup SHIN, Dong Jin KIM, Hoh Gyu HAHN, Kyung Il CHOI, Ghilsoo NAM, Kye Jung SHIN, Soon Bang KANG, Eun Joo ROH, Dong Yun SHIN, Seon Hee SEO, Hyewhon RHIM, Gyo Chang KEUM, Key-Sun KIM, Chan Seong CHEONG, Eunice Eun-Kyeong KIM, Cheolju LEE, Youngsoo KIM, Kee Hyun CHOI, Kee Dal NAM, Woong Seo PARK, Yong Koo KANG, Hye Jin CHUNG
  • Publication number: 20090325979
    Abstract: Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.
    Type: Application
    Filed: June 26, 2009
    Publication date: December 31, 2009
    Inventors: Kyung Il CHOI, Ghilsoo Nam, Hye Ran Kim, Hyewhon Rhim, Seon Hee Seo, Yoon Jee Kim, Hee Sup Shin, Dong Jin Kim, Ae Nim Pae, Hye Jin Chung, Yong Seo Cho, Hyunah Choo, Eun Joo Roh, Soon Bang Kang, Kye Jung Shin, Hoh Gyu Hahn, Dong Yun Shin, Chan Seong Cheong, Kee Dal Nam, Yong Koo Kang, Jae Kyun Lee, Woong Seo Park, Youngsoo Kim, Eunice Eun-Kyeong Kim, Key-Sun Kim, Hesson Chung, Gyo Chang Keum, Cheolju Lee, Kee Hyun Choi
  • Patent number: 7544686
    Abstract: The present invention provides for novel piperazinylalkylpyrazole derivatives, the preparation method thereof and the selective T-type calcium channel blocking activity thereof. Particularly, it provides a piperazinylalkylpyrazole derivative as represented by the formula set forth below or its pharmaceutically acceptable salts, and its preparation method thereof. The compound of Formula 1 is a novel piperazinylalkylpyrazole derivative, which particulary has T-type Ca2+ channel blocking effect and thus can be useful as a therapeutic agent for nerve and muscle pain.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: June 9, 2009
    Assignee: Korea Institute of Science and Technology
    Inventors: Ghilsoo Nam, Kyung-Il Choi, Hun Yeong Koh, Ae Nim Pae, Hyewhon Rhim, In-Sung Choi
  • Publication number: 20070049604
    Abstract: The present invention provides for novel piperazinylalkylpyrazole derivatives, the preparation method thereof and the selective T-type calcium channel blocking activity thereof. Particularly, it provides a piperazinylalkylpyrazole derivative as represented by the formula set forth below or its pharmaceutically acceptable salts, and its preparation method thereof. The compound of Formula 1 is a novel piperazinylalkylpyrazole derivative, which particulary has T-type Ca2+ channel blocking effect and thus can be useful as a therapeutic agent for nerve and muscle pain.
    Type: Application
    Filed: August 25, 2006
    Publication date: March 1, 2007
    Applicant: Korea Institute of Science and Technology
    Inventors: Ghilsoo Nam, Kyung Choi, Hun Koh, Ae Pae, Hyewhon Rhim, In-Sung Choi